Ligand validation:5JR3

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 5JR3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5JR3_SAH_A_401	98%	30%	0.064	0.984	1.12	1.65	2	4	0	0	100%	1
5JR3_SAH_B_401	93%	31%	0.081	0.976	1.1	1.62	2	2	0	0	100%	1
5JR3_SAH_C_401	81%	32%	0.093	0.946	1.08	1.61	2	5	0	0	100%	1
5EEH_SAH_A_401	98%	28%	0.06	0.979	1.11	1.74	3	5	0	0	100%	1
1TW2_SAH_B_1635	83%	4%	0.113	0.972	2.77	2.89	4	11	3	0	100%	1
1TW3_SAH_B_1635	69%	5%	0.122	0.936	2.7	2.65	4	9	5	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8QXQ_SAH_A_401	100%	51%	0.028	0.994	0.84	1.04	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.